POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME

Authors

  • Lola T. Daminova
  • Abror Sh. Kasimov
  • Zafar B. Abdashimov

Keywords:

NSAID, PPIs, Cytochrome P450, gastropathy, gastroduodenal damage

Author Biographies

Lola T. Daminova

MD., Professor of the Department of Subjects of Therapeutic Direction No. 2,
Tashkent State Dental Institute, Tashkent, Uzbekistan

Abror Sh. Kasimov

PhD., Deputy Chief Physician of the Multidisciplinary Clinic of
Tashkent Medical Academy, Tashkent, Uzbekistan

Zafar B. Abdashimov

PhD., Associate Professor of the Department of Pharmacology and Clinical Pharmacy, Tashkent Pharmaceutical Institute, Tashkent, Uzbekistan

Downloads

Published

2022-10-03

How to Cite

Lola T. Daminova, Abror Sh. Kasimov, & Zafar B. Abdashimov. (2022). POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME. Central Asian Journal of Medicine, (3), 159-166. Retrieved from https://journals.tma.uz/index.php/cajm/article/view/515

Issue

No. 3 (2022): CAJM

Section

Articles